about
Application of multivariate statistical procedures to identify transcription factors that correlate with MRP2, 3, and 4 mRNA in adult human liversInherited disorders of bilirubin clearanceInteraction of Isoflavones with the BCRP/ABCG2 Drug TransporterEffects of developmental deltamethrin exposure on white adipose tissue gene expressionAlteration of the expression of pesticide-metabolizing enzymes in pregnant mice: potential role in the increased vulnerability of the developing brainRegional expression of the BCRP/ABCG2 transporter in term human placentasIdentification of modulators of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) in a mouse liver gene expression compendiumRegulation of Drug Disposition Gene Expression in Pregnant Mice with Car Receptor ActivationDown-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling.Regulation of the placental BCRP transporter by PPAR gamma.Fibroblast growth factor 15 deficiency impairs liver regeneration in mice.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.Correlation between genotype and phenotypic categorization of staphylococci based on methicillin susceptibility and resistanceTranscriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.MDR1 transporter protects against paraquat-induced toxicity in human and mouse proximal tubule cells.Management of rosiglitazone-induced edema: two case reports and a review of the literature.Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendiumDifferential Fmo3 gene expression in various liver injury models involving hepatic oxidative stress in miceIn Vitro Screening of Environmental Chemicals Identifies Zearalenone as a Novel Substrate of the Placental BCRP/ABCG2 Transporter.Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working GroupThe traditional ayurvedic medicine, Eugenia jambolana (Jamun fruit), decreases liver inflammation, injury and fibrosis during cholestasis.Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice.Renal efflux transporter expression in pregnant mice with Type I diabetesRepression of hepatobiliary transporters and differential regulation of classic and alternative bile acid pathways in mice during pregnancy.Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor.Isoform-Specific Regulation of Mouse Carboxylesterase Expression and Activity by Prototypical Transcriptional Activators.Environmentally Relevant Concentrations of Arsenite Induce Dose-Dependent Differential Genotoxicity Through Poly(ADP-Ribose) Polymerase Inhibition and Oxidative Stress in Mouse Thymus Cells.Nrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1)Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy.Regulation of hepatic phase II metabolism in pregnant miceGenetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein TransporterEvaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting.Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment.Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta.Coordinated induction of Nrf2 target genes protects against iron nitrilotriacetate (FeNTA)-induced nephrotoxicity.
P50
Q24643974-356EF2C2-561B-43C1-B758-D93C58B448A4Q26776470-CB42A710-CD42-4C2E-B4C0-7FC3C004978BQ26801110-A354D08E-F04C-4A7F-AF6A-27506F9EF3ECQ28386680-E9C0E477-2845-4620-BDD4-D33707FF8635Q28393806-BC664B62-0063-410A-AEF5-263B4A0B4AA4Q28397221-13591DDB-908F-4DAB-9757-F05ECCB17DC4Q28543435-24855179-8AAA-4CC0-8458-51AA0E644A51Q28822475-277B345E-453A-4230-A2A1-A43B421A4B08Q32180024-2BBD9C3A-9E62-42AB-BE85-24827BAC6E89Q32185956-3BB4AE6F-4A62-4FF8-9702-461B21F87598Q33626562-ECCAED75-B8C5-47F7-A64D-18F7F277CF06Q33714593-5A8C70E4-BF2F-4E0B-BFB3-63DEB3E3CFEBQ33755271-23962FD5-6723-4A79-9459-7407077166A0Q33973203-B0635FEC-954F-45C4-8952-73969FB58CBBQ34214639-6A10CF82-E216-4D96-ADB3-A95196294223Q34736271-9BCE93F3-6AC9-4937-8AD0-283C571186D2Q34979014-F447C2AF-4C37-490F-B028-1C333100A6F9Q35565444-C28A6315-51AC-472A-95C8-5D2170126544Q35575682-F0D09CA5-C178-4E73-AD4A-4D9B80B5CFDDQ35596350-C6272954-EF06-480B-BC2E-29066E352C47Q35655939-767FA779-3A3A-45A6-9418-CD45DC75E69AQ35667919-A481F5A5-30F3-4ED3-AC9B-DDF36794F086Q35823049-5A398CFE-6301-4061-81FF-24B01EED9592Q35828534-AF5AC3F8-6372-47AA-B5F0-6148A4146357Q35994016-FE1ED26B-934A-4224-ABB6-BB3D4AD58C73Q36017543-8EAACE8C-01A3-4721-98ED-6096BC614BEFQ36400841-D5FAA586-D6B0-4673-8505-72AE2F81AD56Q36407344-1EA4B85F-2AF3-4DE6-9CA4-B72D86238123Q36412220-58D1B020-45D5-4C03-A3E8-9AF81F824523Q36463474-BBCE2353-1A79-431B-9C62-25E9D8333392Q36468267-09D188C3-259F-4813-A50D-0AFCD2053411Q36468922-D233BE61-F161-4795-8085-677AD0B5DC7FQ36468929-D57A835A-8627-42F0-9B67-CE577DC3C8B1Q36471339-9016592F-1415-48C7-84DE-F5475E173187Q36497592-BE6ABABA-712E-41A0-999A-56D69D4E4A3BQ36733503-0F156210-E228-4ED5-951A-75FED7913C13Q36875879-92E53D40-7116-4DF9-878F-6AA542C2BD0AQ36944317-5F614712-4F4C-4405-A05A-E719EA1BECF6Q36953232-D1C09C42-47EA-4194-9266-69DEDAB4CD1AQ36971772-0F5E6BEE-B8A6-4BA7-B694-E962218E65A6
P50
description
researcher ORCID ID = 0000-0002-0032-1037
@en
wetenschapper
@nl
name
Lauren M Aleksunes
@ast
Lauren M Aleksunes
@en
Lauren M Aleksunes
@es
Lauren M Aleksunes
@nl
type
label
Lauren M Aleksunes
@ast
Lauren M Aleksunes
@en
Lauren M Aleksunes
@es
Lauren M Aleksunes
@nl
prefLabel
Lauren M Aleksunes
@ast
Lauren M Aleksunes
@en
Lauren M Aleksunes
@es
Lauren M Aleksunes
@nl
P106
P1153
6506436088
P31
P496
0000-0002-0032-1037